Impact of in vitro Costimulation with TLR2, TLR4 and TLR9 Agonists and HIV-1 on Antigen-Presenting Cell Activation

Publisher： Karger

E-ISSN： 1423-0100|58|2|122-129

ISSN： 0300-5526

Source： Intervirology, Vol.58, Iss.2, 2015-04, pp. : 122-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipopolysaccharide induces sCD40L release through human platelets TLR4, but not TLR2 and TLR9

By Cognasse Fabrice   Lafarge Sandrine   Chavarin Patricia   Acquart Sophie   Garraud Olivier  

Intensive Care Medicine, Vol. 33, Iss. 2, 2007-02 ,pp. : 382-384

Springer Publishing Company

Access to resources Recommend Favorite

Postulates for validating TLR4 agonists

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 2, 2015-02 ,pp. : 356-370

John Wiley & Sons Inc

Access to resources Recommend Favorite

Toll‐like receptor (TLR) 2 agonists ameliorate indomethacin‐induced murine ileitis by suppressing the TLR4 signaling

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 11, 2015-11 ,pp. : 1610-1617

John Wiley & Sons Inc

Access to resources Recommend Favorite

The TLR4‐associated phospholipase D1 activation is crucial for Der f 2‐induced IL‐13 production

By  

ALLERGY, Vol. 70, Iss. 12, 2015-12 ,pp. : 1569-1579

John Wiley & Sons Inc

Access to resources Recommend Favorite

A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T‐cell immunity in vivo

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 42, Iss. 1, 2012-01 ,pp. : 101-109

John Wiley & Sons Inc

Access to resources Recommend Favorite